| |
| |
|
| Insider
Information: |
Alta Biopharma Partners Ii Lp |
| Relationship: |
10% Owner |
| City: |
San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
1,264,299 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$1,542,445 |
|
|
| Total
Shares |
1,264,299 |
|
|
| Total
Value |
$1,542,445 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Rigel Pharmaceuticals Inc |
RIGL |
10% Owner |
2004-02-19 |
0 |
2004-05-07 |
1,264,299 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
16 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| RIGL |
Rigel Pharmaceuticals Inc |
See footnotes |
– – • |
2004-05-07 |
4 |
S |
$21.50 |
$66,650 |
I/I |
(3,100) |
8,050 |
|
- |
|
| RIGL |
Rigel Pharmaceuticals Inc |
See footnotes |
– – • |
2004-05-03 |
4 |
S |
$21.31 |
$2,028,398 |
I/I |
(95,200) |
8,119 |
|
- |
|
| RIGL |
Rigel Pharmaceuticals Inc |
See footnotes |
– – • |
2004-04-30 |
4 |
S |
$21.25 |
$178,500 |
I/I |
(8,400) |
10,245 |
|
- |
|
| RIGL |
Rigel Pharmaceuticals Inc |
See footnotes |
– – • |
2004-04-29 |
4 |
S |
$21.25 |
$739,514 |
I/I |
(34,800) |
10,433 |
|
- |
|
| RIGL |
Rigel Pharmaceuticals Inc |
See footnotes |
– – • |
2004-04-28 |
4 |
S |
$21.25 |
$170,000 |
I/I |
(8,000) |
11,210 |
|
- |
|
| RIGL |
Rigel Pharmaceuticals Inc |
See footnotes |
– – • |
2004-04-27 |
4 |
S |
$21.26 |
$153,038 |
I/I |
(7,200) |
11,389 |
|
- |
|
| RIGL |
Rigel Pharmaceuticals Inc |
See footnotes |
– – • |
2004-04-26 |
4 |
S |
$21.26 |
$36,142 |
I/I |
(1,700) |
11,550 |
|
- |
|
| RIGL |
Rigel Pharmaceuticals Inc |
See footnotes |
– – • |
2004-04-23 |
4 |
S |
$21.32 |
$279,285 |
I/I |
(13,100) |
11,588 |
|
- |
|
| RIGL |
Rigel Pharmaceuticals Inc |
See footnotes |
– – • |
2004-04-22 |
4 |
S |
$21.25 |
$40,375 |
I/I |
(1,900) |
11,881 |
|
- |
|
| RIGL |
Rigel Pharmaceuticals Inc |
See footnotes |
– – • |
2004-04-21 |
4 |
S |
$21.27 |
$146,747 |
I/I |
(6,900) |
11,923 |
|
- |
|
| RIGL |
Rigel Pharmaceuticals Inc |
See footnotes |
– – • |
2004-04-07 |
4 |
S |
$21.00 |
$1,266,342 |
I/I |
(60,300) |
12,077 |
|
- |
|
| RIGL |
Rigel Pharmaceuticals Inc |
See footnotes |
– – • |
2004-04-06 |
4 |
S |
$21.00 |
$203,700 |
I/I |
(9,700) |
13,424 |
|
- |
|
| RIGL |
Rigel Pharmaceuticals Inc |
See footnotes |
– – • |
2004-04-05 |
4 |
S |
$22.95 |
$27,540 |
I/I |
(1,200) |
13,641 |
|
- |
|
| RIGL |
Rigel Pharmaceuticals Inc |
See footnotes |
– – • |
2004-03-24 |
4 |
S |
$20.00 |
$149,740 |
I/I |
(7,487) |
13,668 |
|
- |
|
| RIGL |
Rigel Pharmaceuticals Inc |
See footnotes |
– – • |
2004-02-19 |
4/A |
S |
$20.00 |
$1,489,280 |
I/I |
(74,464) |
13,835 |
|
- |
|
| RIGL |
Rigel Pharmaceuticals Inc |
See footnotes |
– – • |
2004-02-19 |
4 |
S |
$20.00 |
$2,233,920 |
I/I |
(111,696) |
13,003 |
|
- |
|
16 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
